Author: Peter Johnson

As the UK Government has triggered Article 50, our chief clinician looks at what the Brexit negotiations could mean for cancer.

Our chief clinician offers his thoughts on new data looking at one aspect of the effects of certain cancer treatments across the NHS in England.

Our chief clinician, Professor Peter Johnson, gives his take on the recent announcement of changes to NHS England’s Cancer Drugs Fund.

We caught up with our chief clinician, Professor Peter Johnson, about the findings of a new report looking at the state of NHS cancer services.